Search Results - "Jovelin, T."

Usefulness of an HIV DNA resistance genotypic test in patients who are candidates for a switch to the rilpivirine/emtricitabine/tenofovir disoproxil fumarate combination by Lambert-Niclot, S, Allavena, C, Grude, M, Flandre, P, Sayon, S, Andre, E, Wirden, M, Rodallec, A, Jovelin, T, Katlama, C, Calvez, V, Raffi, F, Marcelin, A-G

“…In the context of a rilpivirine/emtricitabine/tenofovir disoproxil fumarate switch in HIV-1-infected patients with at least 1 year of virological success, we…”
Get full text

Reaching the Second and Third Joint United Nations Programme on Human Immunodeficiency Virus (HIV)/AIDS 90-90-90 Targets Is Accompanied by a Dramatic Reduction in Primary HIV Infection and in Recent HIV Infections in a Large French Nationwide HIV Cohort by Le Guillou, Adrien, Pugliese, Pascal, Raffi, François, Cabie, André, Cuzin, Lise, Katlama, Christine, Allavena, Clotilde, Drame, Moustapha, Cotte, Laurent, Bani-Sadr, Firouzé

“…Abstract Background In late 2013, France was one of the first countries to recommend initiation of combination antiretroviral therapy (cART) irrespective of…”
Get full text

Switching from abacavir/lamivudine plus nevirapine to abacavir/lamivudine/dolutegravir in virologically controlled HIV-infected adults (SWAD study) by Allavena, C., Volteau, C., André-Garnier, E., Guimard, T., Hall, N., Khatchatourian, L., Morrier, M., Billaud, E., Rodallec, A., Reliquet, V., Jovelin, T., Le Guen, L., Perré, P., Grégoire, M., Raffi, F.

“…•The SWAD study shows that switching from nevirapine to dolutegravir in combination with abacavir/lamivudine in 53 HIV-infected virologically controlled…”
Get full text

Hepatitis C virus incidence in HIV‐infected and in preexposure prophylaxis (PrEP)‐using men having sex with men by Cotte, Laurent, Raffi, François, Gagneux‐Brunon, Amandine, Palich, Romain, Hoen, Bruno, Ferry, T., Boibieux, A., Miailhes, P., Valour, F., Schlienger, I., Lippmann, J., Braun, E., Longuet, C., Brochier, C., Degroodt, S., Breaud, S., Ceppi, C., Courjon, J., Cottalorda, J., Cottalorda, J., Demonchy, E., Durant, J., Durant, J., Etienne, C., Etienne, C., Fuzibet, J. G., Risso, K., Mondain, V., Oran, N., Pillet, S., Prouvost‐Keller, B., Brégigeon, S., Orticoni, M., Jaquet, I., Galie, S., Martinet, P., Ivanova, A., Debreux, C., Lions, C., Quertainmont, Y., Teicher, E., Vittecoq, D., Deradji, O., Barrail‐Tran, A., Consigny, P. H., Cessot, G., Goesch, J., Benabdelmoumen, G., Lanternier, F., Charlier, C., Rouzaud, C., Touam, F., Louisin, C., Duvivier, C., Lortholary, O., Danion, F., Biezunski, N., Delpierre, C., Piffaut, M., Merle de Boever, C., Montes, B., Montoya Ferrer, A., Tribout, V., Allavena, C., Biron, C., Brunet‐Cartier, C., Jovelin, T., Morineau, P., Reliquet, V., Hue, H., Sécher, S., Ferré, V., Grossi, O., Boucher, A., Huleux, T., Lafon‐Desmurs, B., Pradier, M., Robineau, O., Berger, J. L., Lebrun, D., Bani‐Sadr, F., Fischer, P., Partisani, M., Priester, M., Bernard‐Henry, C., Mautort, E., Frésard, A., Baud, O., Corbin, V., Casanova, S., Drobacheff‐Thiébaut, C., Muret, P., Abel, S., Césaire, R., Cuzin, L., Nguyen, D., Pierre‐François, S., Fabre, I., Curlier, E., Herrmann‐Storck, C.

“…Background & Aims HCV incidence still appears on the rise in HIV‐infected MSM in France. We assessed the incidence of HCV infection in HIV‐positive and in…”
Get full text

Measles seroprevalence in human immunodeficiency virus-infected adults born in the era of measles vaccination by Lefebvre, Maeva, Secher, Solène, Bouchez, Sabelline, Vandamme, Yves-Marie, Fialaire, Pascale, Leautez, Sophie, Blanchi, Sophie, Michau, Christophe, Coste-Burel, Marianne, Brunet-Cartier, Cécile, Reliquet, Véronique, Gregoire, Antoine, Raffi, François, Allavena, Clotilde

“…Widespread use of the measles vaccine should lead to the elimination of this disease. Here we study the seroprevalence of measles in a cohort of adults living…”
Get full text

Epidemiological impact of Neisseria gonorrhoeae and Chlamydia trachomatis screening in men having sex with men: a modelling study by Flaig, Julien, Hocqueloux, Laurent, Palich, Romain, Cuzin, Lise, Robineau, Olivier, Pugliese, Pascal, Delpierre, Cyrille, Voirin, Nicolas, Cotte, Laurent

“…The impact of the systematic screening of (NG) and (CT) in men having sex with men (MSM) on these pathogens' epidemiology remains unclear. We conducted a…”
Get more information

Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study by Gantner, P, Pugliese, P, Bani‐Sadr, F, Joly, V, Poizot‐Martin, I, Garraffo, R, Peytavin, G, Fafi‐Kremer, S, Rey, D, Bonnet, B., Bouchez, S., Hall, N., Aubry, O., Point, P., Besnier, M., Grossi, O., Lefebvre, M., Hüe, H., Soria, A., Pineau, S., André‐Garnier, E., Rodallec, A., Brégigeon, S., Faucher, O., Orticoni, M., Soavi, M. J., Ressiot, E., Pinot, I., Ducassou, M. J., Bertone, H., Gallie, S., Ritleng, A. S., Ivanova, A., Blanco‐Betancourt, C., Alvarez, M., Biezunski, N., Debard, A., Delobel, P., Delpierre, C., Marchou, B., Martin‐Blondel, G., Mularczyk, M., Garipuy, D., Saune, K., Marcel, M., Puntis, E., Ceppi, C., Cottalorda, J., Dellamonica, P., Demonchy, E., Dunais, B., Ferrando, S., Fuzibet, J. G., Risso, K., Mondain, V., Naqvi, A., Oran, N., Perbost, I., Pillet, S., Prouvost‐Keller, B., Wehrlen‐Pugliese, S., Rosenthal, E., Roger, P. M., Vandame, S., Ajana, F., Baclet, V., Huleux, T. H., Melliez, H., Viget, N., Aissi, E., Meybeck, A., Agher, R., Katlama, C., Mackoumbou‐Nkouka, C., Louni, F., Descamps, D., Cotte, L., Peyramond, D., Chidiac, C., Ader, F., Biron, F., Boibieux, A., Miailhes, P., Perpoint, T., Dahoud, F., Lippmann, J., Koffi, J., Longuet, C., Guéripel, V., Augustin‐Normand, C., Degroodt, S., Batard, M. L., Cheneau, C., Mautort, E., Fischer, P., Partisani, M., Priester, M., Bani‐Sadr, F., Berger, J. L., Hentzien, M.

Get full text

Usefulness of an HIV DNA resistance genotypic test in patients who are candidates for a switch to the rilpivirine/emtricitabine/tenofovir disoproxil fumarate combination by Lambert-Niclot, S., Allavena, C., Grude, M., Flandre, P., Sayon, S., Andre, E., Wirden, M., Rodallec, A., Jovelin, T., Katlama, C., Calvez, V., Raffi, F., Marcelin, A.-G.

Get full text

Reaching the Second and Third Joint United Nations Programme on Human Immunodeficiency Virus (HIV)/AIDS 90-90-90 Targets Is Accompanied by a Dramatic Reduction in Primary HIV Infection and in Recent HIV Infections in a Large French Nationwide HIV Cohort by Le Guillou, Adrien, Pugliese, Pascal, Raffi, François, Cabie, André, Cuzin, Lise, Katlama, Christine, Allavena, Clotilde, Drame, Moustapha, Cotte, Laurent, Bani-Sadr, Firouzé, Orticoni, M, Soavi, M, Luquet- Besson, I, Ressiot, E, Carta- Padovani, M, Ducassou, M, Bertone, H, Galie, S, Galinier, A, Monclar, M, Ritleng, A, Ivanova, A, Blanco-Betancourt, C, Lions, C, Poizot-Martin, I, Dhiver, C, Saadia Mokhtari, M, Ménard, A, Tissot Dupont, H, Toméi, C, Meddeb, L, Belkhir, A, Ravaux, I, Alvarez, M, Biezunski, N, Debard, A, Delpierre, C, Lansalot, P, Lelièvre, L, Martin-Blondel, G, Piffaut, M, Porte, L, Saune, K, Delobel, P, Pugliese, P, Breaud, S, Ceppi, C, Chirio, D, Cua, E, Dellamonica, P, Demonchy, E, de Monte, A, Durant, J, Etienne, C, Ferrando, S, Garraffo, R, Michelangeli, C, Mondain, V, Allavena, C, Bernaud, C, Billaud, E, Biron, C, Bonnet, B, Bouchez, S, Boutoille, D, Brunet-Cartier, C, Deschanvres, C, Gaborit, B, Hall, N, Jovelin, T, Le Turnier, P, Morineau, P, Reliquet, V, Sécher, S, Cavellec, M, Soria, A, Ferré, V, André-Garnier, E, Rodallec, A, Lefebvre, M, Grossi, O, Aubry, O, Raffi, F, Amazzough, K, Benabdelmoumen, G, Bossi, P, Cessot, G, Charlier, C, Consigny, P, Danion, F, Dureault, A, Duvivier, C, Goesch, J, Guery, R, Henry, B, Jidar, K, Lanternier, F, Loubet, P, Lortholary, O, Louisin, C

“…Background In late 2013, France was one of the first countries to recommend initiation of combination antiretroviral therapy (cART) irrespective of CD4 cell…”
Get full text

CMV+ Serostatus Associates Negatively with CD4:CD8 Ratio Normalization in Controlled HIV-Infected Patients on cART by Poizot-Martin, Isabelle, Allavena, Clotilde, Duvivier, Claudine, Cano, Carla Eliana, Guillouet de Salvador, Francine, Rey, David, Dellamonica, Pierre, Cuzin, Lise, Cheret, Antoine, Hoen, Bruno

“…Cytomegalovirus (CMV) infection is common among HIV-infected patients but its repercussion on the course of CD4+ and CD8+ T cells after cART initiation remains…”
Get full text

Effectiveness and safety of saquinavir/ritonavir in HIV-infected pregnant women: INEMA cohort by Brunet, C., Reliquet, V., Jovelin, T., Venisse, N., Winer, N., Bui, E., Le Moal, G., Perfezou, P., De Saint Martin, L., Raffi, F.

“…The authors had for aim to describe the effectiveness and the safety of a saquinavir/ritonavir (SQV/r) regimen, 1000/100mg twice daily, in HIV-infected…”
Get full text

No increased risk of Kaposi sarcoma relapse in patients with controlled HIV‐1 infection after switching protease inhibitor‐based antiretroviral therapy by Makinson, Alain, Arvieux, Cedric, Chirouze, C., Brunel, AS, Chevalier, E., Mrozek, N., Aumeran, C., Goncalvez, E., Lamaury, I., Ouissa, R., Receveur, MC, Clavel, C., Markowicz, S., Merrien, D., Guimard, T., Bollangier, O., Boucher, D., Boibieux, A., Cannesson, O., Chiarello, P., Ferry, T., Pouderoux, C., Triffault‐Fillit, C., Valour, F., Charre, C., Trabaud, M.A., Belkhir, AY, Madrid, A., Tissot‐Dupont, H., Brégigeon, S., Ducassou, M.J., Galie, S., Colson, H., Ivanova, A., Debreux, C., Cabras, O., Dupin de Majoubert, R., Najioullah, F., Pasquier, J., Varache, C., Atoui, N., Montes, B., Lefèvre, B., Jeanmaire, E., Hénard, S., Frentiu, E., Bouillon, MP, Raffi, F., Billaud, E., Biron, C., Bonnet, B., Bouchez, S., Deschanvres, C., Grossi, O., Morineau, P., Soria, A., Pugliese, P., Chirio, D., Cua, E., Dellamonica, P., De Monte, A., Durant, J., Maka, A., Giaché, S., Lerolle, N., Deradji, O., Castro, A., Ghosn, J., Lescure, FX, Le Gac, S., Duvivier, C., Alby‐Laurent, F., Amazzough, K., Bossi, P., Jidar, K., Lafont, E., Lourenco, J., Valantin, MA, Blanc, C., Katlama, C., Romaru, J., Tattevin, P., Souala, F., Benezit, F., Pronier, C., Morlat, C., Poisson‐Vannier, M., Jovelin, T., Frésard, A., Ronat, V., Lucht, F., Batard, ML, Delobel, P., Biezunski, N., Martin‐Blondel, G., Piffaut, M., Saune, K., Ajana, F., Baclet, V., Pradier, M.

“…Objectives Our aim was to assess if switching from a protease inhibitors (PI)‐based regimen to a PI‐free one is associated with an increased risk of Kaposi…”
Get full text

Factors associated with deaths from suicide in a French nationwide HIV‐infected cohort by Hentzien, M, Cabie, A, Pugliese, P, Poizot‐Martin, I, Duvivier, C, Valantin, M‐A, Kaladjian, A, Dramé, M, Dellamonica, P, Cuzin, L, Cabié, A, Delpierre, C, Allavena, C, Katlama, C, Peytavin, G, Cheret, A, Chidiac, C, Isnard‐Bagnis, C, Cotte, L, Peyramond, D, Joly, V, Jovelin, T, Saune, K, Roger, P. M., May, T, Brégigeon, S, Soavi, M. J., Ressiot, E, Carta‐Padovani, M, Ducassou, M. J., Jaquet, I, Galie, S, Galinier, A, Landon, M, Ivanova, A, Debreux, C, Lions, C, Biezunski, N, Fourcade, C, Marchou, B, Martin‐Blondel, G, Porte, L, Mularczyk, M, Garipuy, D, Lepain, I, Marcel, M, Puntis, E, Bentz, L, Cua, E, Cottalorda, J, Fuzibet, J. G., Mondain, V, Naqvi, A, Prouvost‐Keller, B, Pradier, C, Wehrlen‐Pugliese, S, Bonnet, B, Bouchez, S, Brunet, C, Hall, N, Morineau, P, Reliquet, V, Aubry, O, Point, P, Besnier, M, Hüe, H, Cavellec, M, Soria, A, Sécher, S, André‐Garnier, E, Rodallec, A, Ferré, V, Lefebvre, M, Grossi, O, Choisy, P, Agher, R, Pierre‐François, S, Liautaud, B, Fischer, P, Partisani, M, Cheneau, C, Priester, M, Bernard‐Henry, C, Batard, M. L., Mautort, E, Gardiennet, Q, Berger, J. L., N'Guyen, Y, Lebrun, D, Migault, C, Kmiec, I, Ferry, T, Boibieux, A, Perpoint, T, Schlienger, I, Lippmann, J, Braun, E, Koffi, J, Guéripel, V, Degroodt, S

“…Objectives People living with HIV (PLHIV) are at a higher risk of dying by suicide than the general population. Epidemiological data regarding determinants of…”
Get full text

Kaposi sarcoma among people living with HIV in the French DAT’AIDS cohort between 2010 and 2015 by Poizot‐Martin, I., Obry‐Roguet, V., Lions, C., Huleux, T., Ferry, T., Allavena, C., Bani‐Sadr, F., Lamaury, I., Brégigeon, S., Muret, P., Lesens, O., Prouteau, J., Bonijoly, T., Daniel, C., Perré, P., Guimard, T., Becker, A., Boibieux, A., Cotte, L., Degroodt, S., Colson, P., Meddeb, L., Mokhtari, M., Motte, A., Raoux, A., Ravaux, I., Tamalet, C., Tissot Dupont, H., Orticoni, M., Galinier, A., Martinet, P., Abel, S., Cabras, O., Cuzin, L., Guitteaud, K., Pierre‐François, S., Osei, L., Atoui, N., Boyer, L., Hoen, B., Bernaud, C., Biron, C., Hall, N., Ferré, V., André‐Garnier, E., Rodallec, A., Lefebvre, M., Aubry, O., Breaud, S., Chirio, D., Garraffo, R., Mondain, V., Naqvi, A., Perbost, I., Pradier, C., Prouvost‐Keller, B., Roger, P.M., Wehrlen‐Pugliese, S., Hocqueloux, L., Sève, A., Boulard, C., Goujard, C., Quertainmont, Y., Teicher, E., Deradji, O., Rioux, C., Lariven, S., Lescure, F.X., Le Gac, S., Charpentier, C., Peytavin, G., Bossi, P., Cessot, G., Consigny, P.H., Danion, F., Goesch, J., Lanternier, F., Pilmis, B., Touam, F., Berger, J.L., Brodard, V., Revest, M., Lemaitre, F., Poisson‐Vanier, M., Jovelin, T., Fischer, P., Cheneau, C., Mautort, E., Fafi‐Kremer, S., Alvarez, M., Biezunski, N., Debard, A., Lansalot, P., Saune, K., Aïssi, E., Baclet, V., Pradier, M., Robineau, O., Viget, N., Valette, M.

“…Background Although antiretroviral therapy (ART) has reduced the risk of Kaposi sarcoma (KS), KS cases still occur in HIV‐infected people. Objective To…”
Get full text

Risk of diabetes in HIV‐infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort by Provoost, A., Dramé, M., Cotte, L., Cuzin, L., Garraffo, R., Rey, D., Raffi, F., Poizot‐Martin, I., Pugliese, P., Enel, P., Obry‐Roguet, V., Faucher, O., Bregigeon, S., Ménard, A., Biezunski, N., Cuzin, L., Delobel, P., Fourcade, C., Porte, L., Mularczyk, M., Garipuy, D., Lepain, I., Marcel, M., Metsu, D., Puntis, E., Pugliese, P., Ceppi, C., Cottalorda, J., Ferrando, S., Fuzibet, J. G., Garraffo, R., Naqvi, A., Perbost, I., Pillet, S., Prouvost‐Keller, B., Pradier, C., Roger, P. M., Rosenthal, E., Dellamonica, P., Raffi, F., Bonnet, B., Brunet, C., Jovelin, T., Bernaud, C., Morineau, P., Reliquet, V., Hüe, H., Cavellec, M., Soria, A., André‐Garnier, E., Rodallec, A., Ferré, V., Leguen, L., Lefebvre, M., Jacomet, C., Cheret, A., Choisy, P., Duvivier, C., Valantin, M. A., Agher, R., Katlama, C., Isnard‐Bagnis, C., Peytavin, G., Joly, V., Yazdanpanah, Y., Cabié, A., Pierre‐François, S., Liautaud, B., Fischer, P., Cheneau, C., Priester, M., Bernard‐Henry, C., de Mautort, E., May, T., Hoen, B., Chirouze, C., Gardiennet, Q., Bani‐Sadr, F., Berger, J. L., N'Guyen, Y., Lambert, D., Lebrun, D., Kmiec, I., Brodard, V., Cotte, L., Chidiac, C., Ferry, T., Ader, F., Biron, F., Boibieux, A., Miailhes, P., Perpoint, T., Schlienger, I., Braun, E., Koffi, J., Longuet, C., Guéripel, V., Augustin‐Normand, C., Degroodt, S., Peyramond, D.

“…Summary Background Both human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections have been reportedly associated with a higher risk of…”
Get full text

Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients – “En route for eradication”? by Pradat, Pierre, Pugliese, Pascal, Poizot-Martin, Isabelle, Valantin, Marc-Antoine, Cuzin, Lise, Reynes, Jacques, Billaud, Eric, Huleux, Thomas, Bani-Sadr, Firouze, Rey, David, Frésard, Anne, Jacomet, Christine, Duvivier, Claudine, Cheret, Antoine, Hustache-Mathieu, Laurent, Hoen, Bruno, Cabié, André, Cotte, Laurent

“…Summary Objectives Direct-Acting Antivirals (DAAs) opened a new era in HCV treatment. We report the impact of HCV treatment in French HIV-HCV coinfected…”
Get full text

Ageing with HIV: do comorbidities and polymedication drive treatment optimization? by Cuzin, L, Katlama, C, Pugliese, P, Bernaud, C, Rey, D, Chirouze, C, Bani‐Sadr, F, Cabié, A, Zaegel‐Faucher, O., Orticoni, M., Luquet‐Besson, I., Ressiot, E., Carta‐ Padovani, M., Bertone, H., Galie, S., Monclar, M., Ritleng, A. S., Ivanova, A., Marchou, B., Massip, P., Obadia, M., Alvarez, M., Martin‐Blondel, G., Chauveau, M., Garipuy, D., Labau, E., Puntis, E., Ceppi, C., Cua, E., Dellamonica, P., Demonchy, E., Durant, J., Etienne, C., Ferrando, S., Garraffo, R., Mondain, V., Perbost, I., Pillet, S., Prouvost‐Keller, B., Pradier, C., Wehrlen‐Pugliese, S., Rosenthal, E., Sausse, S., Roger, P. M., Allavena, C., Billaud, E., Biron, C., Bouchez, S., Boutoille, D., Jovelin, T., Morineau, P., Reliquet, V., Hue, H., Larmet, L., Pineau, S., Ferré, V., André‐Garnier, E., Rodallec, A., Lefebvre, M., Point, P., Choisy, P., Yazdanpanah, Y., Landman, R., Valantin, M. A., Agher, R., Lortholary, O., Avettand‐Fenoel, V., Rouzioux, C., Touam, F., Usubillaga, R., Benhadj, K., Abel, S., Martial, J., Fischer, P., Partisani, M., Cheneau, C., Priester, M., Batard, M. L., Foltzer, A., Hoen, B., Jacomet, C., Laurichesse, H., Lesens, O., Vidal, M., Mrozek, N., Baud, O., Beytout, J., Coban, D., Casanova, S., Berger, J. L., N'Guyen, Y., Lambert, D., Kmiec, I., Hentzien, M., Chidiac, C., Ader, F., Ferry, T., Miailhes, P., Perpoint, T., Degroodt, S.

“…Objectives The aim of the study was to describe the ageing HIV‐infected population (> 50 years old) and their current antiretroviral therapy (ART),…”
Get full text

HIV-related excess mortality and age-related comorbidities in patients with HIV aged ≥60: a relative survival analysis in the French Dat’AIDS cohort by Hentzien, Maxime, Dramé, Moustapha, Delpierre, Cyrille, Allavena, Clotilde, Cabié, André, Cuzin, Lise, Rey, David, Pugliese, Pascal, Hédelin, Guy, Bani-Sadr, Firouzé

“…ObjectiveThe objective was to evaluate the association between age-related comorbidities (ARCs) and 5-year HIV-related excess mortality in people living with…”
Get full text

Metabolic syndrome in French HIV-infected patients: prevalence and predictive factors after 3 years of antiretroviral therapy by Biron, Antoine, Bobin-Dubigeon, Christine, Volteau, Christelle, Piroth, Lionel, Perré, Philippe, Leport, Catherine, Prazuck, Thierry, Jovelin, Thomas, Billard, Martine, Sébille, Veronique, Bard, Jean-Marie, Raffi, François, Biron, Charlotte

“…Treatment of HIV infection with highly active antiretroviral therapy can induce metabolic complications and increase the risk of developing the metabolic…”
Get more information

Switch to Ritonavir-Boosted versus Unboosted Atazanavir plus Raltegravir Dual-Drug Therapy Leads to Similar Efficacy and Safety Outcomes in Clinical Practice by Gantner, Pierre, Bani-Sadr, Firouze, Garraffo, Rodolphe, Roger, Pierre-Marie, Treger, Michèle, Jovelin, Thomas, Pugliese, Pascal, Rey, David

“…To assess immunovirological response, safety and pharmacokinetic of NRTI-sparing regimen dual therapy of atazanavir (ATV) and raltegravir (RAL) in maintenance…”
Get full text